Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release May 24 2022
Business
May 24 2022
4 min read

Press Release May 24 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 24-May-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg and 801 mg.

View Attachment